Colin John Meyer

Insider Reports History

Entity
Individual
Location
C/O Reata Pharmaceuticals, Inc., 2801 Gateway Dr. Suite 150, Irving, TX
Signature
/s/ Tracy Herson, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Colin John Meyer:

Stock Role Class Num Shares Value Price $ Report Date Ownership
REATA PHARMACEUTICALS INC Chief Innovation Officer Class A common stock 0 $172.03 Sep 26, 2023 Direct
REATA PHARMACEUTICALS INC Chief Innovation Officer Class B common stock 0 $172.03 Sep 26, 2023 Direct
REATA PHARMACEUTICALS INC Chief Innovation Officer Employee Stock Option (right to buy) 0 Sep 26, 2023 Direct

Insider Reports Filed by Colin John Meyer

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RETA REATA PHARMACEUTICALS INC Sep 26, 2023 12 $0 4 Sep 26, 2023 Chief Innovation Officer
RETA REATA PHARMACEUTICALS INC Aug 15, 2023 2 -$463K 4 Aug 17, 2023 Chief Innovation Officer
RETA REATA PHARMACEUTICALS INC Jul 6, 2023 1 $0 4 Jul 10, 2023 Chief Innovation Officer
RETA REATA PHARMACEUTICALS INC May 15, 2023 3 -$527K 4 May 17, 2023 Chief Innovation Officer
RETA REATA PHARMACEUTICALS INC Mar 7, 2023 1 -$52.5K 4 Mar 8, 2023 Chief Innovation Officer
RETA REATA PHARMACEUTICALS INC Mar 2, 2023 10 -$7.17M 4 Mar 6, 2023 Chief Innovation Officer
RETA REATA PHARMACEUTICALS INC Feb 28, 2023 2 $0 4 Mar 1, 2023 Chief Innovation Officer
RETA REATA PHARMACEUTICALS INC Jan 3, 2023 2 $0 4 Jan 4, 2023 Chief Innovation Officer
RETA REATA PHARMACEUTICALS INC Jan 3, 2022 2 $0 4 Jan 5, 2022 Chief Research Officer
RETA REATA PHARMACEUTICALS INC Jun 14, 2021 16 -$8.33M 4 Jun 16, 2021 Chief Research Officer